Hematologic Cancer Clinical Trials

A listing of Hematologic Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 270 clinical trials
A Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies

This is a phase 1, 2-part, global, multicenter, open-label, PK, safety and tolerability study of oral tazemetostat in subjects with either advanced solid tumors, or hematological malignancies and normal hepatic function or moderate, or severe hepatic impairment.

acquired immunodeficiency syndrome (aids)
b-cell lymphoma
oral contraception
renal function
measurable disease
  • 0 views
  • 16 Feb, 2024
  • 5 locations
Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies (Reboot-101)

This phase studies the engineered red blood cells with PD-1 inhibitor pembrolizumab(WTX212), the natural biological metabolic function of red blood cells can make the carried pembrolizumab directionally distributed in the spleen tissue and activitate T cells, suggesting that this product may solve the problem that PD-1 treatment failure.

  • 0 views
  • 01 Feb, 2023
  • 1 location
A Study to Identify Breast Cancer (IDBC)

Detecting cancer as early as possible is key to achieving positive outcomes in response to diagnosis and treatment. The current project is aimed at validating a novel blood-based breast cancer identification test (Syantra DX Breast Cancer) that has been developed by Syantra Inc. Syantra DX Breast Cancer measures gene expression …

invasive breast cancer
breast cancer
gene expression
mammogram
cancer
  • 0 views
  • 05 Aug, 2020
Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies

This project aims to bank blood samples from a cohort of patients treated with CAR-T cell for hematological malignancies in Montpellier University Hospital. Clinical data related to samples will be collected. This samples will be used to determine factors influencing efficacy of CAR-T cells treatments.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology

The retrospective cohort study INFINITY will be an instrument to analyze the current practice of precision oncology in the real-world setting. It will provide insight into real-world biomarker-directed treatment of cancer patients not eligible for standard therapies. The study will retrospectively collect medical records' data of patients who received a …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Register of Blood Stem Cell Transplantation

Register of patients with blood stem cell transplantations (autologous, allogen).

cell transplantation
  • 0 views
  • 16 Feb, 2024
  • 1 location
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

metastasis
radiation therapy, targeted
bone marrow transplant
oropharyngeal
viral test
  • 0 views
  • 16 Feb, 2024
  • 576 locations
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Nucleix EpiCheck tests analyzes the methylation pattern in a panel of DNA methylation biomarkers and determines whether this pattern is consistent with cancer under test or with non-cancer tissue. This study is being performed as part of the development process of the Pan Cancer EpiCheck test which includes the identification …

cfdna
cancer
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Determination of Blood Tumor Cells

Magnetic nanoparticles coated with anti-EpCAM or anti-CD52 antibodies will be tested ex-vivo in patients blood .

leukemia
lymphoma
hematologic malignancy
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients

Impact of the Comprehensive Geriatric Assessment on the Quality of Life of elderly onco-hematologic patients' candidates for complex antitumoral therapies: clinical and biological correlatives

hematologic malignancy
cancer
  • 0 views
  • 05 Aug, 2020